AbbVie to Anchor Research Triangle with $1.4 Billion Pharmaceutical Manufacturing Campus
Pharmaceutical giant AbbVie invests $1.4 billion in a new 185-acre Research Triangle manufacturing campus, creating 734 jobs and boosting the NC biotech sector.
By: AXL Media
Published: Apr 28, 2026, 10:03 AM EDT
Source: Bisnow
Project Scope and Strategic Facilities
The expansive campus is designed to support AbbVie’s specialized medicine portfolio, specifically focusing on immunology, neuroscience, and oncology. Construction is slated to begin in late 2026, with a target delivery date by the end of 2028. The first phase will feature:
Small Volume Parenteral (SVP) drug product manufacturing units.
Next-generation laboratories for R&D and quality control.
Logistics infrastructure including a massive warehouse and administrative offices.
On-site employee wellness facilities to support a projected workforce of 734 permanent employees, ranging from research scientists to manufacturing operators.
Categories
Topics
Related Coverage
- Biotech Giants and Damon Runyon Scientists Convene in Cambridge to Advance the 2026 Accelerating Cancer Cures Initiative
- Thermo Fisher Executive Outlines AI Driven Quality Framework to Accelerate Pharmaceutical Development Timelines
- The Real Brokerage to Acquire Re/Max in Major $550 Million Industry Merger
- Succession Strategy: How Greg Abel Can Emulate Tim Cook’s Playbook Following Buffett’s Retirement